4//SEC Filing
Deutsch Barry M. 4
Accession 0001346302-21-000006
CIK 0001346302other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:06 PM ET
Size
5.0 KB
Accession
0001346302-21-000006
Insider Transaction Report
Form 4
Deutsch Barry M.
Chief Financial Officer
Transactions
- Award
Common Stock
2021-01-29+115,000→ 208,090 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These restricted stock units vest in three substantially equal annual installments beginning on January 29, 2022.
Documents
Issuer
XERIS PHARMACEUTICALS INC
CIK 0001346302
Entity typeother
Related Parties
1- filerCIK 0001289407
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 4:06 PM ET
- Size
- 5.0 KB